This document contains a list of government hospitals in the state of Karnataka, India. It includes the name of each district, the name and full address of government hospitals in each district, and contact details like email addresses and phone numbers of the hospitals. There are a total of 75 districts listed with one or more government hospitals provided for each district across Karnataka.
Blood coagulation involves a balance between procoagulants and anticoagulants that allows blood to clot normally after a vascular injury. Hemostasis is achieved through vascular constriction, formation of a platelet plug, and ultimately a blood clot. Coagulation disorders can result in too little or too much clotting. Anticoagulants like heparin and warfarin are used to treat and prevent thrombotic conditions by inhibiting different steps in the coagulation cascade, but also increase the risk of bleeding.
This document discusses direct oral anticoagulants (DOACs), including their mechanism of action, pharmacological properties, and comparisons to standard anticoagulants. It addresses the use of DOACs in special situations, reversal of their effects, preoperative use, and combinations with antiplatelet drugs. Guidance is provided on switching between anticoagulants and managing DOACs in various clinical scenarios.
This document provides information about the drug irbesartan, including its trade names, dosage forms, pharmacological mechanisms, pharmacokinetics, indications and usage, interactions, side effects, contraindications, and storage. Irbesartan is an angiotensin II receptor antagonist used to treat hypertension. It is well absorbed orally and highly protein bound. Common side effects include diarrhea, heartburn, dizziness and fatigue. Irbesartan has few drug interactions and may be taken with or without food.
This document provides information about diuretics, including their definition, classification, mechanisms of action, therapeutic uses, adverse effects, and contraindications. It focuses on different classes of diuretics - carbonic anhydrase inhibitors like acetazolamide, osmotic diuretics like mannitol, and loop diuretics like furosemide. It discusses how each class works, its pharmacokinetics, uses to treat conditions like glaucoma and edema, potential side effects, and situations where it should not be used. The document is intended to educate on the topic of diuretic drugs.
Ticagrelor is a reversible P2Y12 inhibitor that was developed to overcome limitations of clopidogrel such as variable metabolism and slow onset of action. The PLATO trial found ticagrelor to be superior to clopidogrel in reducing cardiovascular events in ACS patients with no increase in major bleeding. The PEGASUS trial found ticagrelor reduced cardiovascular events in stable patients with prior MI compared to placebo on aspirin. However, the EUCLID trial found ticagrelor was no better than clopidogrel in reducing events in PAD patients and increased dyspnea. The TREAT trial is investigating ticagrelor vs clopidogrel after fibrinolytic therapy in STE
Platelets play an important role in hemostasis and thrombosis. Antiplatelet drugs like aspirin and clopidogrel are commonly used to prevent heart attacks and strokes. Aspirin works by irreversibly inhibiting the COX-1 enzyme in platelets to block thromboxane A2 production. Clopidogrel is a prodrug that irreversibly inhibits the P2Y12 receptor on platelets. Clinical trials show dual antiplatelet therapy with aspirin and clopidogrel reduces cardiovascular events in conditions like acute coronary syndrome compared to aspirin alone, though it increases bleeding risk. Newer P2Y12 inhibitors like prasugrel and ticagrelor are more potent but also associated with
This document discusses the history and uses of the diabetes medication metformin. It traces metformin back to galega officinalis which was used in the Middle Ages to reduce diabetes symptoms. Metformin was first identified and studied in the 1950s and approved for use in the US in 1994. The document highlights that metformin is now recommended as a first-line treatment for type 2 diabetes and has been shown to reduce cardiovascular events and mortality in diabetes patients. Metformin is also effective in preventing or delaying the onset of diabetes in patients with prediabetes.
Blood coagulation involves a balance between procoagulants and anticoagulants that allows blood to clot normally after a vascular injury. Hemostasis is achieved through vascular constriction, formation of a platelet plug, and ultimately a blood clot. Coagulation disorders can result in too little or too much clotting. Anticoagulants like heparin and warfarin are used to treat and prevent thrombotic conditions by inhibiting different steps in the coagulation cascade, but also increase the risk of bleeding.
This document discusses direct oral anticoagulants (DOACs), including their mechanism of action, pharmacological properties, and comparisons to standard anticoagulants. It addresses the use of DOACs in special situations, reversal of their effects, preoperative use, and combinations with antiplatelet drugs. Guidance is provided on switching between anticoagulants and managing DOACs in various clinical scenarios.
This document provides information about the drug irbesartan, including its trade names, dosage forms, pharmacological mechanisms, pharmacokinetics, indications and usage, interactions, side effects, contraindications, and storage. Irbesartan is an angiotensin II receptor antagonist used to treat hypertension. It is well absorbed orally and highly protein bound. Common side effects include diarrhea, heartburn, dizziness and fatigue. Irbesartan has few drug interactions and may be taken with or without food.
This document provides information about diuretics, including their definition, classification, mechanisms of action, therapeutic uses, adverse effects, and contraindications. It focuses on different classes of diuretics - carbonic anhydrase inhibitors like acetazolamide, osmotic diuretics like mannitol, and loop diuretics like furosemide. It discusses how each class works, its pharmacokinetics, uses to treat conditions like glaucoma and edema, potential side effects, and situations where it should not be used. The document is intended to educate on the topic of diuretic drugs.
Ticagrelor is a reversible P2Y12 inhibitor that was developed to overcome limitations of clopidogrel such as variable metabolism and slow onset of action. The PLATO trial found ticagrelor to be superior to clopidogrel in reducing cardiovascular events in ACS patients with no increase in major bleeding. The PEGASUS trial found ticagrelor reduced cardiovascular events in stable patients with prior MI compared to placebo on aspirin. However, the EUCLID trial found ticagrelor was no better than clopidogrel in reducing events in PAD patients and increased dyspnea. The TREAT trial is investigating ticagrelor vs clopidogrel after fibrinolytic therapy in STE
Platelets play an important role in hemostasis and thrombosis. Antiplatelet drugs like aspirin and clopidogrel are commonly used to prevent heart attacks and strokes. Aspirin works by irreversibly inhibiting the COX-1 enzyme in platelets to block thromboxane A2 production. Clopidogrel is a prodrug that irreversibly inhibits the P2Y12 receptor on platelets. Clinical trials show dual antiplatelet therapy with aspirin and clopidogrel reduces cardiovascular events in conditions like acute coronary syndrome compared to aspirin alone, though it increases bleeding risk. Newer P2Y12 inhibitors like prasugrel and ticagrelor are more potent but also associated with
This document discusses the history and uses of the diabetes medication metformin. It traces metformin back to galega officinalis which was used in the Middle Ages to reduce diabetes symptoms. Metformin was first identified and studied in the 1950s and approved for use in the US in 1994. The document highlights that metformin is now recommended as a first-line treatment for type 2 diabetes and has been shown to reduce cardiovascular events and mortality in diabetes patients. Metformin is also effective in preventing or delaying the onset of diabetes in patients with prediabetes.
Drug Interactions of ADP receptor Blockers (Antiplatelets)Naina Mohamed, PhD
· ADP receptor Blockers (Antiplatelets) include Thienopyridines (Clopidogrel, Prasugrel, Ticlopidine) and Non-Thienopyridines (Ticagrelor, Cangrelor, Elinogrel ).
· The risk of adverse effects could be reduced by healthcare professionals through the screening, education, and follow up on suspected drug interactions.
This document summarizes various screening methods for anti-glaucoma drugs. It describes models that induce elevated intraocular pressure (IOP) through ocular injections, reducing serum osmolarity, application of lasers, and use of steroids. These include alpha-chymotrypsin injection, methylcellulose injection, autologous ghost red blood cell injection, hyaluronic acid injection, water loading, hypertonic saline injection, laser treatment of the trabecular meshwork, episcleral veins or cornea, and topical or injected steroid administration. The models are used to test potential anti-glaucoma drugs by evaluating their ability to lower IOP.
This document discusses coagulants and anticoagulants. It describes how thrombosis occurs via venous and arterial pathways and the process of hemostasis. Coagulation involves a balance between procoagulants and anticoagulants. Common coagulation factors and pathways are outlined. Vitamin K and other coagulants like fibrinogen and antihemophilic factor are discussed. Anticoagulants include heparins, oral anticoagulants like warfarin, and other agents. Mechanisms, uses, and adverse effects of various coagulants and anticoagulants are summarized.
This document discusses anticoagulants and antiplatelet drugs. It describes how anticoagulants prevent blood clotting by inhibiting coagulation factors, while some occur naturally in animals. Common anticoagulants discussed include heparin, low molecular weight heparins like enoxaparin, and vitamin K antagonists like warfarin. The mechanisms and sites of action are explained for different classes of anticoagulants. Advantages of LMWH over unfractionated heparin include better bioavailability and more predictable response. Bleeding is a major adverse effect of anticoagulant overdose.
This document discusses several newer antiarrhythmic drugs, including ranolazine, vernakalant, ivabradine, celivarone, budiodarone, and tecadenoson. It provides details on the mechanisms of action, clinical trials, efficacy, and safety profiles of these drugs. Ranolazine, vernakalant, and budiodarone have shown efficacy in cardioversion or rate control of atrial fibrillation, while ivabradine reduces heart rate without affecting contractility. Celivarone and tecadenoson are being investigated for maintaining sinus rhythm and terminating supraventricular tachycardias, respectively.
The history of dialysis began in the 18th century with advances in materials like collodion membranes that could be used for diffusion. In the early 20th century, researchers like Abel and Kolff began developing early dialysis machines. Kolff's 1943 dialyzer was the first working machine used to treat acute renal failure. In 1945, Kolff treated the first patient with end-stage renal disease using hemodialysis, allowing her to regain consciousness. Throughout the 1950s and 1960s, dialysis treatment expanded but demand still far exceeded capacity, with challenges in finding long-term treatment for chronic kidney disease patients.
there are several limitation in VKA,to over come these problem NOACs came in picture but still limited indication for NOACs currently,required further study inter and intra comparison between anticoagulants.
This document provides an overview of anti-platelet agents used to prevent thrombosis. It discusses the classification of anti-platelet drugs including aspirin, clopidogrel, prasugrel, dipyridamole, ticlopidine, and glycoprotein IIb/IIIa inhibitors like abciximab, eptifibatide and tirofiban. Newer agents described include cangrelor, ticagrelor and SCH530348. The summary emphasizes that aspirin remains the cornerstone therapy due to its proven clinical benefit and cost-effectiveness, while newer drugs act through distinct mechanisms to provide additive effects in combination with aspirin.
This document provides information on loop diuretics and potassium sparing diuretics. It begins with an overview of normal urine formation and sites of renal reabsorption. It then classifies diuretics and discusses the mechanisms and sites of action of loop diuretics like furosemide and torsemide as well as potassium sparing diuretics like spironolactone and amiloride. It notes their therapeutic uses, interactions, and resistance. In recent years, new loop diuretic compounds like CRE 10904 have been developed.
This document summarizes anti-platelet agents and their mechanisms of action. It discusses the pathophysiology of thrombus formation and platelet activation pathways. Targets for anti-platelet therapy include blocking ADP receptors, phosphodiesterase inhibitors, cyclooxygenase-1, and the glycoprotein IIb/IIIa receptor. Aspirin irreversibly inhibits cyclooxygenase-1, preventing thromboxane A2 production. Clopidogrel inhibits the P2Y12 ADP receptor. Glycoprotein IIb/IIIa antagonists like abciximab, tirofiban, and eptifibatide prevent fibrinogen binding. Clinical trials demonstrate the efficacy of these agents in
This document describes the light/dark box test used to assay anxiety responses in rodents. The test uses the natural aversion of rodents to brightly lit spaces to create approach-avoidance conflict. Rodents are placed in a box divided into a light and dark chamber, and their transitions and time spent in the light chamber are recorded. Increased time in the light chamber and transitions between chambers indicates anxiolytic activity, while benzodiazepines have reliably produced this effect. The procedure involves placing a rodent in the light chamber and recording behaviors like latency to enter the dark chamber over 5 minutes. Results are compared to controls to assess anxiolytic or anxiogenic drug effects.
Vasopressin receptor antagonists, also known as vaptans, are aquaretic drugs that promote loss of water while retaining electrolytes. They work by blocking vasopressin receptors, mainly the V2 receptor, reducing urine concentration and increasing free water clearance. Some approved vaptans include conivaptan, tolvaptan, and lixivaptan, which are used to treat hyponatremia associated with conditions like SIADH, congestive heart failure, and cirrhosis. Ongoing clinical trials are investigating additional vaptans for these indications.
This document discusses antiplatelet therapy and P2Y12 platelet inhibition. It notes that dual antiplatelet therapy with aspirin and a P2Y12 inhibitor such as clopidogrel, prasugrel, or ticagrelor is the standard treatment for patients with acute coronary syndrome. It reviews the mechanisms of action and pharmacological properties of different antiplatelet drugs. It also summarizes key trials that have evaluated antiplatelet therapies and provides recommendations from guidelines on treatment selection and duration based on a patient's risk of bleeding and thrombosis.
This document discusses various anticoagulant agents including heparin, low molecular weight heparins, synthetic heparin derivatives like fondaparinux and idraparinux, direct thrombin inhibitors like lepirudin and bivalirudin, and synthetic thrombin inhibitor argatroban. It provides details on their mechanisms of action, pharmacokinetics, therapeutic ranges, and comparisons between unfractionated heparin and low molecular weight heparins. Protamine sulfate is discussed as an antagonist for reversing heparin overdose.
This document discusses extracorporeal therapies and renal replacement therapy (RRT). It describes different types of RRT including intermittent hemodialysis, continuous dialysis, and their principles and setup. It covers non-renal uses of RRT such as for sepsis, acute respiratory distress syndrome, congestive heart failure, and more. It also describes hemoperfusion, which uses activated charcoal or resin to adsorb molecules from blood, and issues around preventing clotting during the process.
The document discusses various anticoagulants and their mechanisms of action, including heparin, low molecular weight heparins, warfarin, and direct thrombin inhibitors. It also covers fibrinolytic agents and their role in dissolving blood clots. The key mechanisms discussed are how heparin activates antithrombin III to inactivate thrombin and factor Xa, how warfarin inhibits vitamin K to decrease production of coagulation factors, and how fibrinolytic agents activate plasminogen to break down fibrin clots. Monitoring and clinical uses of these drug classes are also summarized.
This document summarizes screening models for diuretic agents. It discusses various in vitro and in vivo models including isolated tubule preparation, carbonic anhydrase inhibition assay, patch clamp technique, Lipschitz test, saluretic activity in rats, stop flow technique, clearance method, and micropuncture technique. It provides details on the principles, procedures, and evaluations of these models for studying mechanisms and effects of diuretic agents. The models allow localization of sites of action and analysis of renal transport processes to evaluate diuretics and their carbonic anhydrase inhibiting or potassium sparing effects.
The document discusses anticoagulants and their use in preventing blood clots. It describes tests like PT, INR, and PTT that are used to monitor anticoagulant therapy and provides normal ranges. PT measures clotting factors while INR standardizes PT results between labs. PTT evaluates heparin therapy and clotting factors. Warfarin users should have an INR of 2.0-3.0 for basic needs or 2.5-3.5 if at high risk of clots.
This document contains a list of 86 hospitals in Chennai with details including name, address, contact number and email. It provides information on specialty, location and contact details of hospitals in a tabular format for easy reference. The list includes details of major government and private hospitals across different areas of Chennai for treatment in specialties such as eye care, orthopedics, ENT, kidney, general medicine and more.
This document lists contact information for various hospitals that are part of Religare Health Insurance's hospital network in Karnataka. It provides addresses and phone numbers for over 100 hospitals located across multiple cities in Karnataka, including Bangalore, Belgaum, Bellary, Bijapur, Chikmagalur, Chitradurga, Davanagere, Dharwad, Gadag, Gokak, Gulbarga, Hassan, Hubli, Karwar, Kolar, Madikeri, Malur, Mandya, Mangalore, and Manipal.
Drug Interactions of ADP receptor Blockers (Antiplatelets)Naina Mohamed, PhD
· ADP receptor Blockers (Antiplatelets) include Thienopyridines (Clopidogrel, Prasugrel, Ticlopidine) and Non-Thienopyridines (Ticagrelor, Cangrelor, Elinogrel ).
· The risk of adverse effects could be reduced by healthcare professionals through the screening, education, and follow up on suspected drug interactions.
This document summarizes various screening methods for anti-glaucoma drugs. It describes models that induce elevated intraocular pressure (IOP) through ocular injections, reducing serum osmolarity, application of lasers, and use of steroids. These include alpha-chymotrypsin injection, methylcellulose injection, autologous ghost red blood cell injection, hyaluronic acid injection, water loading, hypertonic saline injection, laser treatment of the trabecular meshwork, episcleral veins or cornea, and topical or injected steroid administration. The models are used to test potential anti-glaucoma drugs by evaluating their ability to lower IOP.
This document discusses coagulants and anticoagulants. It describes how thrombosis occurs via venous and arterial pathways and the process of hemostasis. Coagulation involves a balance between procoagulants and anticoagulants. Common coagulation factors and pathways are outlined. Vitamin K and other coagulants like fibrinogen and antihemophilic factor are discussed. Anticoagulants include heparins, oral anticoagulants like warfarin, and other agents. Mechanisms, uses, and adverse effects of various coagulants and anticoagulants are summarized.
This document discusses anticoagulants and antiplatelet drugs. It describes how anticoagulants prevent blood clotting by inhibiting coagulation factors, while some occur naturally in animals. Common anticoagulants discussed include heparin, low molecular weight heparins like enoxaparin, and vitamin K antagonists like warfarin. The mechanisms and sites of action are explained for different classes of anticoagulants. Advantages of LMWH over unfractionated heparin include better bioavailability and more predictable response. Bleeding is a major adverse effect of anticoagulant overdose.
This document discusses several newer antiarrhythmic drugs, including ranolazine, vernakalant, ivabradine, celivarone, budiodarone, and tecadenoson. It provides details on the mechanisms of action, clinical trials, efficacy, and safety profiles of these drugs. Ranolazine, vernakalant, and budiodarone have shown efficacy in cardioversion or rate control of atrial fibrillation, while ivabradine reduces heart rate without affecting contractility. Celivarone and tecadenoson are being investigated for maintaining sinus rhythm and terminating supraventricular tachycardias, respectively.
The history of dialysis began in the 18th century with advances in materials like collodion membranes that could be used for diffusion. In the early 20th century, researchers like Abel and Kolff began developing early dialysis machines. Kolff's 1943 dialyzer was the first working machine used to treat acute renal failure. In 1945, Kolff treated the first patient with end-stage renal disease using hemodialysis, allowing her to regain consciousness. Throughout the 1950s and 1960s, dialysis treatment expanded but demand still far exceeded capacity, with challenges in finding long-term treatment for chronic kidney disease patients.
there are several limitation in VKA,to over come these problem NOACs came in picture but still limited indication for NOACs currently,required further study inter and intra comparison between anticoagulants.
This document provides an overview of anti-platelet agents used to prevent thrombosis. It discusses the classification of anti-platelet drugs including aspirin, clopidogrel, prasugrel, dipyridamole, ticlopidine, and glycoprotein IIb/IIIa inhibitors like abciximab, eptifibatide and tirofiban. Newer agents described include cangrelor, ticagrelor and SCH530348. The summary emphasizes that aspirin remains the cornerstone therapy due to its proven clinical benefit and cost-effectiveness, while newer drugs act through distinct mechanisms to provide additive effects in combination with aspirin.
This document provides information on loop diuretics and potassium sparing diuretics. It begins with an overview of normal urine formation and sites of renal reabsorption. It then classifies diuretics and discusses the mechanisms and sites of action of loop diuretics like furosemide and torsemide as well as potassium sparing diuretics like spironolactone and amiloride. It notes their therapeutic uses, interactions, and resistance. In recent years, new loop diuretic compounds like CRE 10904 have been developed.
This document summarizes anti-platelet agents and their mechanisms of action. It discusses the pathophysiology of thrombus formation and platelet activation pathways. Targets for anti-platelet therapy include blocking ADP receptors, phosphodiesterase inhibitors, cyclooxygenase-1, and the glycoprotein IIb/IIIa receptor. Aspirin irreversibly inhibits cyclooxygenase-1, preventing thromboxane A2 production. Clopidogrel inhibits the P2Y12 ADP receptor. Glycoprotein IIb/IIIa antagonists like abciximab, tirofiban, and eptifibatide prevent fibrinogen binding. Clinical trials demonstrate the efficacy of these agents in
This document describes the light/dark box test used to assay anxiety responses in rodents. The test uses the natural aversion of rodents to brightly lit spaces to create approach-avoidance conflict. Rodents are placed in a box divided into a light and dark chamber, and their transitions and time spent in the light chamber are recorded. Increased time in the light chamber and transitions between chambers indicates anxiolytic activity, while benzodiazepines have reliably produced this effect. The procedure involves placing a rodent in the light chamber and recording behaviors like latency to enter the dark chamber over 5 minutes. Results are compared to controls to assess anxiolytic or anxiogenic drug effects.
Vasopressin receptor antagonists, also known as vaptans, are aquaretic drugs that promote loss of water while retaining electrolytes. They work by blocking vasopressin receptors, mainly the V2 receptor, reducing urine concentration and increasing free water clearance. Some approved vaptans include conivaptan, tolvaptan, and lixivaptan, which are used to treat hyponatremia associated with conditions like SIADH, congestive heart failure, and cirrhosis. Ongoing clinical trials are investigating additional vaptans for these indications.
This document discusses antiplatelet therapy and P2Y12 platelet inhibition. It notes that dual antiplatelet therapy with aspirin and a P2Y12 inhibitor such as clopidogrel, prasugrel, or ticagrelor is the standard treatment for patients with acute coronary syndrome. It reviews the mechanisms of action and pharmacological properties of different antiplatelet drugs. It also summarizes key trials that have evaluated antiplatelet therapies and provides recommendations from guidelines on treatment selection and duration based on a patient's risk of bleeding and thrombosis.
This document discusses various anticoagulant agents including heparin, low molecular weight heparins, synthetic heparin derivatives like fondaparinux and idraparinux, direct thrombin inhibitors like lepirudin and bivalirudin, and synthetic thrombin inhibitor argatroban. It provides details on their mechanisms of action, pharmacokinetics, therapeutic ranges, and comparisons between unfractionated heparin and low molecular weight heparins. Protamine sulfate is discussed as an antagonist for reversing heparin overdose.
This document discusses extracorporeal therapies and renal replacement therapy (RRT). It describes different types of RRT including intermittent hemodialysis, continuous dialysis, and their principles and setup. It covers non-renal uses of RRT such as for sepsis, acute respiratory distress syndrome, congestive heart failure, and more. It also describes hemoperfusion, which uses activated charcoal or resin to adsorb molecules from blood, and issues around preventing clotting during the process.
The document discusses various anticoagulants and their mechanisms of action, including heparin, low molecular weight heparins, warfarin, and direct thrombin inhibitors. It also covers fibrinolytic agents and their role in dissolving blood clots. The key mechanisms discussed are how heparin activates antithrombin III to inactivate thrombin and factor Xa, how warfarin inhibits vitamin K to decrease production of coagulation factors, and how fibrinolytic agents activate plasminogen to break down fibrin clots. Monitoring and clinical uses of these drug classes are also summarized.
This document summarizes screening models for diuretic agents. It discusses various in vitro and in vivo models including isolated tubule preparation, carbonic anhydrase inhibition assay, patch clamp technique, Lipschitz test, saluretic activity in rats, stop flow technique, clearance method, and micropuncture technique. It provides details on the principles, procedures, and evaluations of these models for studying mechanisms and effects of diuretic agents. The models allow localization of sites of action and analysis of renal transport processes to evaluate diuretics and their carbonic anhydrase inhibiting or potassium sparing effects.
The document discusses anticoagulants and their use in preventing blood clots. It describes tests like PT, INR, and PTT that are used to monitor anticoagulant therapy and provides normal ranges. PT measures clotting factors while INR standardizes PT results between labs. PTT evaluates heparin therapy and clotting factors. Warfarin users should have an INR of 2.0-3.0 for basic needs or 2.5-3.5 if at high risk of clots.
This document contains a list of 86 hospitals in Chennai with details including name, address, contact number and email. It provides information on specialty, location and contact details of hospitals in a tabular format for easy reference. The list includes details of major government and private hospitals across different areas of Chennai for treatment in specialties such as eye care, orthopedics, ENT, kidney, general medicine and more.
This document lists contact information for various hospitals that are part of Religare Health Insurance's hospital network in Karnataka. It provides addresses and phone numbers for over 100 hospitals located across multiple cities in Karnataka, including Bangalore, Belgaum, Bellary, Bijapur, Chikmagalur, Chitradurga, Davanagere, Dharwad, Gadag, Gokak, Gulbarga, Hassan, Hubli, Karwar, Kolar, Madikeri, Malur, Mandya, Mangalore, and Manipal.
This document lists 70 monitoring centres across India under the Pharmacovigilance Programme of India. It provides details such as the centre name, coordinator name, contact details, and scope of activities for monitoring centres in the states of Andhra Pradesh, Arunachal Pradesh, Assam, Bihar, Chhattisgarh, Goa, Gujarat, Haryana, Himachal Pradesh, Jammu and Kashmir, Jharkhand, Karnataka, and others. The centres monitor adverse drug reactions and support activities like the National Tuberculosis Control Programme.
The document provides a list of medical officers and their contact details from various government hospitals, medical colleges and primary health centres across districts in Tamil Nadu. It is authorizing these medical officers to issue compulsory health certificates for pilgrims of the Amarnath Yatra pilgrimage in 2020. The document contains names of districts, blocks, hospitals and primary health centres along with the contact details of resident medical officers in charge of issuing health certificates in Tamil Nadu.
This document contains a list of 148 government primary health centres in Tamil Nadu along with their locations, contact authorities and phone numbers. The health centres are located across various districts including Chennai, Coimbatore, Cuddalore, Dharmapuri, Dindigul, Erode, Kallakurichi, Kancheepuram and Kanyakumari. Each entry also lists the name of the block medical officer and their contact phone number for each primary health centre.
This document provides information about swine flu, including its symptoms and treatment options. It reports that India recorded its second swine flu death and urges readers to be aware of the correct symptoms and where to seek treatment. The post encourages sharing this information widely to help stop the spread of the epidemic and ensure infected people receive timely treatment. It also includes a list of hospitals across India equipped to treat swine flu patients.
This document contains a list of 40 private hospitals in Rajasthan designated as dedicated COVID hospitals (DCH) or dedicated COVID health centers (DCHC). It includes information such as the hospital name, category, type, status, contact details, and some remarks. The hospitals are spread across various districts in Rajasthan and include large medical colleges and smaller private facilities. The list identifies hospitals that have been empaneled under the state government's scheme for treating COVID-19 patients.
The document provides information on Ayushakti Ayurved Centre located in Malad, Mumbai. It is a 15,000 square foot facility offering Ayurvedic treatments and Panchakarma therapies. Treatments include Shirodhara, Vamana, Virechana, Basti, and Nasya. The centre has 8 accommodation rooms and a cafe serving Ayurvedic meals. Consultations are provided by Dr. Pankaj Naram and his team of Ayurvedic physicians trained in pulse diagnosis and Marma Chikitsa. Accommodation rates are listed between Rs. 2,200-3,300 per day and treatment prices range from Rs. 120-450.
This document contains a list of 101 hospitals across various cities in Pakistan. It includes the hospital name, address, phone number, and city for each entry. The hospitals are located in cities such as Abbottabad, Bahawalpur, Faisalabad, Gilgit, Gujranwala, and others. The list is organized alphabetically by city and includes both public and private hospitals.
This document provides contact information for various government representatives and facilities in E Ward, Mumbai including:
- Members of Parliament and the Legislative Assembly for the area
- Chairman of the Ward Committee
- Municipal Councillors
- Contact information for ward control room and different government officers and departments
- Details of police stations, fire stations, schools, colleges, shelters, and public health facilities in the ward.
Dr. Muzzammil Ahmed Siddiqui has provided his curriculum vitae. He received his MBBS degree from Basaveshwara Medical College and Hospital in Chitradurga, Karnataka, India between 2006-2011. He has over 2 years of professional experience working as a resident doctor in ICCU at Khwaja Banda Nawaz Institute of Medical Sciences in Gulbarga. His career objectives include research, healing, and public speaking.
List of Schools in India (Responses).pdfssuser41e0111
This document contains a list of 44 institutions across India that provide educational services for students with disabilities. The institutions are listed with their name, location, contact details, services provided, curriculum followed, and types of disabilities served. The list includes schools, remedial centers, and programs that offer inclusive, special, and adaptive education according to various curriculum standards like CBSE, ICSE, and NIOS. Disabilities served include learning disabilities, ADHD, autism spectrum disorder, Down syndrome, cerebral palsy, visual and hearing impairments, and physical disabilities.
Number of BUMS colleges in India
As on 1st August 2023 in India total 57 Unani Medical Colleges have been approved by National Commission for Indian School of
medicine (NCISM), Ministry of AYUSH, Government of India. Out of total 57 Unani colleges, 11 are government Unani colleges, 6 are
government aided Unani colleges, one is deemed University Unani College, one is central University Unani College, and 38 are private
Unani colleges.
Number of Unani Medical colleges State-wise in India
Maruthupandi is seeking employment as a medical lab technician. He has a Diploma in Medical Laboratory Technology from 2013 with 72% marks. His areas of interest include pathology, hematology, and microbiology. He participated in a 3 month lab training at Adithya Hospital and was captain of his school cricket team.
This document provides contact information for various government representatives and facilities in the G/South Ward of Mumbai, including:
- Members of Parliament and the state legislative assembly for the area
- Ward committee chairman and municipal councillors
- Contact details for police stations, traffic units, hospitals, schools and other local services
- Names and numbers for emergency services like ambulances and fire stations
- NGOs, private businesses and other organizations operating in the ward
The listing is intended as a comprehensive local directory, detailing names, addresses and phone numbers for ease of access to public officials and critical community resources.
This document contains details of 75 Jan Aushadhi medical stores located across various districts in Andhra Pradesh, India. For each store, it provides the store number, address, contact person and their contact details. The stores are spread across the districts of Anantapur, Chittoor, East Godavari, Guntur, Krishna, Kurnool, Nellore, Prakasam, Srikakulam and Visakhapatnam.
This document contains a list of 109 hospitals across West Bengal and the details of their associated Fair Price Medicine Shops including the partner name, contact person, phone numbers. The hospitals are grouped by district and include information such as the district, hospital name, partner name, contact person and their contact details.
Similar to List of Dialysis Centers - Karnataka.pdf (20)
Joker Wigs has been a one-stop-shop for hair products for over 26 years. We provide high-quality hair wigs, hair extensions, hair toppers, hair patch, and more for both men and women.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...rightmanforbloodline
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
2024 HIPAA Compliance Training Guide to the Compliance OfficersConference Panel
Join us for a comprehensive 90-minute lesson designed specifically for Compliance Officers and Practice/Business Managers. This 2024 HIPAA Training session will guide you through the critical steps needed to ensure your practice is fully prepared for upcoming audits. Key updates and significant changes under the Omnibus Rule will be covered, along with the latest applicable updates for 2024.
Key Areas Covered:
Texting and Email Communication: Understand the compliance requirements for electronic communication.
Encryption Standards: Learn what is necessary and what is overhyped.
Medical Messaging and Voice Data: Ensure secure handling of sensitive information.
IT Risk Factors: Identify and mitigate risks related to your IT infrastructure.
Why Attend:
Expert Instructor: Brian Tuttle, with over 20 years in Health IT and Compliance Consulting, brings invaluable experience and knowledge, including insights from over 1000 risk assessments and direct dealings with Office of Civil Rights HIPAA auditors.
Actionable Insights: Receive practical advice on preparing for audits and avoiding common mistakes.
Clarity on Compliance: Clear up misconceptions and understand the reality of HIPAA regulations.
Ensure your compliance strategy is up-to-date and effective. Enroll now and be prepared for the 2024 HIPAA audits.
Enroll Now to secure your spot in this crucial training session and ensure your HIPAA compliance is robust and audit-ready.
https://conferencepanel.com/conference/hipaa-training-for-the-compliance-officer-2024-updates
At Malayali Kerala Spa Ajman, Full Service includes individualized care for every client. We specifically design each massage session for the individual needs of the client. Our therapists are always willing to adjust the treatments based on the client's instruction and feedback. This guarantees that every client receives the treatment they expect.
By offering a variety of massage services, our Ajman Spa Massage Center can tackle physical, mental, and emotional illnesses. In addition, efficient identification of specific health conditions and designing treatment plans accordingly can significantly enhance the quality of massaging.
At Malayali Kerala Spa Ajman, we firmly believe that everyone should have the option to experience top-quality massage services regularly. To achieve that goal we offer cheap massage services in Ajman.
If you are interested in experiencing transformative massage treatment at Malayali Kerala Spa Ajman, you can use our Ajman Massage Center WhatsApp Number to schedule your next massage session.
Contact @ +971 529818279
Visit @ https://malayalikeralaspaajman.com/
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...Ear Solutions (ESPL)
Binaural hearing using two hearing aids instead of one offers numerous advantages, including improved sound localization, enhanced sound quality, better speech understanding in noise, reduced listening effort, and greater overall satisfaction. By leveraging the brain’s natural ability to process sound from both ears, binaural hearing aids provide a more balanced, clear, and comfortable hearing experience. If you or a loved one is considering hearing aids, consult with a hearing care professional at Ear Solutions hearing aid clinic in Mumbai to explore the benefits of binaural hearing and determine the best solution for your hearing needs. Embracing binaural hearing can lead to a richer, more engaging auditory experience and significantly improve your quality of life.
Chandrima Spa Ajman is one of the leading Massage Center in Ajman, which is open 24 hours exclusively for men. Being one of the most affordable Spa in Ajman, we offer Body to Body massage, Kerala Massage, Malayali Massage, Indian Massage, Pakistani Massage Russian massage, Thai massage, Swedish massage, Hot Stone Massage, Deep Tissue Massage, and many more. Indulge in the ultimate massage experience and book your appointment today. We are confident that you will leave our Massage spa feeling refreshed, rejuvenated, and ready to take on the world.
Visit : https://massagespaajman.com/
Call : 052 987 1315
As Mumbai's premier kidney transplant and donation center, L H Hiranandani Hospital Powai is not just a medical facility; it's a beacon of hope where cutting-edge science meets compassionate care, transforming lives and redefining the standards of kidney health in India.
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)bkling
Your mindset is the way you make sense of the world around you. This lens influences the way you think, the way you feel, and how you might behave in certain situations. Let's talk about mindset myths that can get us into trouble and ways to cultivate a mindset to support your cancer survivorship in authentic ways. Let’s Talk About It!
The best massage spa Ajman is Chandrima Spa Ajman, which was founded in 2023 and is exclusively for men 24 hours a day. As of right now, our parent firm has been providing massage services to over 50,000+ clients in Ajman for the past 10 years. It has about 8+ branches. This demonstrates that Chandrima Spa Ajman is among the most reasonably priced spas in Ajman and the ideal place to unwind and rejuvenate. We provide a wide range of Spa massage treatments, including Indian, Pakistani, Kerala, Malayali, and body-to-body massages. Numerous massage techniques are available, including deep tissue, Swedish, Thai, Russian, and hot stone massages. Our massage therapists produce genuinely unique treatments that generate a revitalized sense of inner serenely by fusing modern techniques, the cleanest natural substances, and traditional holistic therapists.
Letter to MREC - application to conduct studyAzreen Aj
Application to conduct study on research title 'Awareness and knowledge of oral cancer and precancer among dental outpatient in Klinik Pergigian Merlimau, Melaka'